Materialise N.V. (MTLS) |
| 6.67 0.19 (2.93%) 05-29 16:00 |
| Open: | 6.515 |
| High: | 6.685 |
| Low: | 6.515 |
| Volume: | 235,147 |
| Market Cap: | 394(M) |
| PE Ratio: | 33.35 |
| Exchange: | NASDAQ Global Select |
| Industry: | Software - Application |
| Sector: | Technology |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 7.81 |
| Resistance 1: | 6.68 |
| Pivot price: | 5.87 |
| Support 1: | 5.69 |
| Support 2: | 5.08 |
| 52w High: | 6.8 |
| 52w Low: | 4.78 |
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
| EPS | 0.200 |
| Book Value | 5.110 |
| PEG Ratio | 1.26 |
| Gross Profit | 2.639 |
| Profit Margin (%) | 3.76 |
| Operating Margin (%) | 3.15 |
| Return on Assets (ttm) | 1.6 |
| Return on Equity (ttm) | 4.0 |
Tue, 26 May 2026
Materialise : Share-Buy Back Program - marketscreener.com
Tue, 26 May 2026
Materialise (NASDAQ: MTLS) details weekly progress in EUR 30m share buy-back - Stock Titan
Mon, 18 May 2026
Materialise (NASDAQ: MTLS) details 748k-share buyback progress and costs - Stock Titan
Sat, 16 May 2026
Materialise NV - Depositary receipt (MTLS) price target increased by 16.07% to 10.55 - MSN
Fri, 15 May 2026
Materialise to Hold Annual Shareholders’ Meeting on June 16, 2026 - Sahm
Tue, 12 May 2026
Are Investors Undervaluing Materialise (MTLS) Right Now? - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |